CRL Nov 2023 150.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:18PM EDT. Market open.
| Previous close | 49.21 |
| Open | N/A |
| Bid | 57.70 |
| Ask | 62.40 |
| Strike | 150.00 |
| Expiry date | 2023-11-17 |
| Day's range | 49.21 - 49.21 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
ZacksCharles River (CRL) Launches LVV-based Gene Therapy Platform
Charles River's (CRL) LVV platform provides medicinal developers with an efficient, dependable route to the clinic and the market.
ZacksCharles River (CRL) Opens a RightSource Lab in Stevenage
Charles River's (CRL) new RightSource facility is likely to provide services to the Stevenage advanced therapy biocluster.
Business WireCharles River Unveils Lentivation Platform to Expedite LVV-based Gene Therapy Manufacturing
WILMINGTON, Mass., September 26, 2023--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its lentiviral vector (LVV) manufacturing platform, Lentivation™. The platform has the capability to reduce LVV manufacturing timelines for gene and gene-modified cell therapies by up to 60 percent, translating to fewer than seven months compared to traditional manufacturing workflows.
© 2023 Yahoo. All rights reserved.
